Today: 20 May 2026
UOB stock edges up as DBS earnings miss jolts Singapore bank shares
9 February 2026
1 min read

UOB stock edges up as DBS earnings miss jolts Singapore bank shares

Singapore, Feb 9, 2026, 15:02 SGT — Regular session.

  • UOB shares picked up roughly 0.8% in afternoon trading, pushing toward the upper end of their one-year range.
  • DBS fell after missing fourth-quarter profit estimates and warning about rate pressures that could linger into 2026.
  • Attention turns to UOB’s full-year numbers, which land Feb. 24.

United Overseas Bank Ltd (UOB) shares climbed roughly 0.8% to S$38.80 in Monday’s afternoon session, with intraday swings from S$38.53 up to S$38.92. Market data shows the stock’s 12-month range running from S$29.00 to S$39.50.

Timing is key here. As Singapore’s banks kick off earnings season, investors are busy gauging just how much this year’s profit margins might get pinched by declining interest rates.

Net interest margin is top of mind — that’s the difference between what banks make on loans and what they pay depositors. If that gap tightens, profits may slide, even if loan demand stays steady.

DBS Group kicked off the week on a sour note, posting a fourth-quarter net profit of S$2.26 billion—a 10% drop from a year earlier, and falling short of the S$2.55 billion analysts had penciled in. Pressure came as net interest margin slipped to 1.93%, and trading income failed to deliver. CGS International’s Tay Wee Kuang and Lim Siew Khee flagged the weaker-than-expected markets trading income as the main culprit behind the fourth quarter miss. “The key driver for the underperformance in 4Q25 was weaker-than-expected markets trading income,” they wrote. CEO Tan Su Shan had a blunt message for clients: “Buckle up, it’s going to be a volatile year.” Results from UOB and OCBC are on deck, slated for Feb. 24 and Feb. 25. Reuters

That doesn’t give UOB much space for a quiet climb before the results. Traders are zeroed in on margins—are they holding up better than expected? Fee income also goes under the microscope as they look for offsets to softer lending spreads.

Credit costs are the other wild card. DBS saw a spike in provisions for bad loans this quarter, forcing a fresh look at asset-quality assumptions across the sector.

UOB’s shares hover near their one-year peak, after a solid run-up in bank stocks. Investors aren’t likely to shrug off fresh signs of higher provisions, slackening loan growth, or a steeper drop in margins—any of those could knock the stock back fast.

UOB’s full-year results drop Feb. 24, giving investors their next clear look at how the bank is handling rate pressure and credit risks. OCBC reports the following day, setting up a direct comparison between the two lenders.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Novo Nordisk Class B stock: what to watch after Hims pulls $49 Wegovy pill copy
Previous Story

Novo Nordisk Class B stock: what to watch after Hims pulls $49 Wegovy pill copy

Nvidia’s Jensen Huang calls Meta AI’s profit pioneer as spending fears swirl
Next Story

Nvidia’s Jensen Huang calls Meta AI’s profit pioneer as spending fears swirl

Go toTop